CONKLING WILLIAM - Insider Non-Derivative Transactions at Cyclo Therapeutics, Inc. (CYTH) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 16, 2024, CONKLING WILLIAM's relationship to Cyclo Therapeutics, Inc. (CYTH) is Director, and currently has 33,570 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CYTH insiders.
Data Source: SEC.
CONKLING WILLIAM - Insider Non-Derivative Transactions of CYTH Common Stock
CONKLING WILLIAM - Insider Non-Derivative Transactions at CYTH
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 17, 2024 | Acquisition -- (Common Stock) | 8731 | 0 | 33570 |
| Jun 4, 2024 | Acquisition -- (Common Stock) | 8594 | 0 | 24839 |
| Feb 14, 2024 | Acquisition -- (Common Stock) | 6330 | 0 | 16245 |
| Nov 29, 2023 | Acquisition -- (Common Stock) | 7466 | 0 | 9915 |
| Aug 19, 2023 | Acquisition -- (Common Stock) | 2449 | 0 | 2449 |